PPARGC1A and chronic kidney disease: NAC-induced AMPK-SIRT1/3-PGC-1α overactivation is particularly important, because it has been reported to diminish mitochondrial ROS production and NLRP3 and TGF-β inflammasome activation in AKI and CKD [25,68,91,92,93].